TRLS — Trellus Health Income Statement
0.000.00%
Last trade - 00:00
- £3.23m
- -£9.47m
- $0.02m
- 30
- 26
- 17
- 13
2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 0 | 0.025 | 0.018 |
Cost of Revenue | |||
Gross Profit | — | 0.025 | 0.018 |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Unusual Expense / Income | |||
Total Operating Expenses | 0.762 | 5.93 | 8.83 |
Operating Profit | -0.762 | -5.9 | -8.81 |
Net Income Before Taxes | -0.762 | -5.9 | -8.81 |
Provision for Income Taxes | |||
Net Income After Taxes | -0.762 | -5.9 | -8.81 |
Net Income Before Extraordinary Items | |||
Net Income | -0.762 | -5.9 | -8.81 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | -0.762 | -5.9 | -8.81 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | -0.005 | -0.045 | -0.054 |
Dividends per Share |